AI English summary of an SEC filing — figures as filed
IDEX IEXIDEX said reported net sales for Q3 2025 were $878.7 million, up 10% from the same period in the prior year, and increased 5% organically, while diluted earnings per common share attributable to IDEX were $1.70, up 8%.
Key points
AI summaryIDEX said reported net sales for Q3 2025 were $878.7 million, up 10% from the same period in the prior year, and increased 5% organically, while diluted earnings per common share attributable to IDEX were $1.70, up 8%.
The company cited contributions from the acquisition of Mott for the increase in net sales for Q3 2025 and the 9 months ended in the prior year period. It said organic sales for the same periods increased 5% and 1%, respectively, driven by positive price across all segments.
IDEX said the effective tax rate was 25.1% for Q3 2025 and 23.8% for the 9 months, compared with 22.9% and 21.9% in the same periods in the prior year, and cited the impact of the enactment of the OBBBA as a factor in the increase.
The company said on September 17, 2025 its Board of Directors authorized the repurchase of an additional $635.0 million of the company's common shares. It added that during the 9 months it repurchased 1.0 million shares at a cost of $175.0 million, and as of September 30 the amount of share repurchase authorization remaining was $999.7 million.
Key figures
Quarter ended September 30, 2025
- Revenue
- $879M
- Operating income
- $186M
- Net income
- $128M
- EPS
- $1.70
- Gross profit
- $391M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q3 Net Sales $878.7 million, Diluted EPS $1.70
IDEX said reported net sales for Q3 2025 were $878.7 million, up 10% from the same period in the prior year, and increased 5% organically, while diluted earnings per common share attributable to IDEX were $1.70, up 8%.
Source · Based on the MD&A text of the filing
Mott Acquisition Contribution and Organic Sales Growth of 5% and 1%
The company cited contributions from the acquisition of Mott for the increase in net sales for Q3 2025 and the 9 months ended in the prior year period. It said organic sales for the same periods increased 5% and 1%, respectively, driven by positive price across all segments.
Source · Based on the MD&A text of the filing
Effective Tax Rate 25.1% for Q3, 23.8% for 9 Months
IDEX said the effective tax rate was 25.1% for Q3 2025 and 23.8% for the 9 months, compared with 22.9% and 21.9% in the same periods in the prior year, and cited the impact of the enactment of the OBBBA as a factor in the increase.
Source · Based on the MD&A text of the filing
Share Repurchases of $175.0 million in 9 Months, Remaining Authorization $999.7 million
The company said on September 17, 2025 its Board of Directors authorized the repurchase of an additional $635.0 million of the company's common shares. It added that during the 9 months it repurchased 1.0 million shares at a cost of $175.0 million, and as of September 30 the amount of share repurchase authorization remaining was $999.7 million.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…